Power Broker
Michael Greeley
Senior Managing Director, Newmark
Boston, MA 02110
Michael Greeley is a Senior Managing Director of Newmark’s Medical-Academic Practice Group in Boston
Phone (617) 863-8618
Michael Greeley is a Senior Managing Director of Newmark’s Medical-Academic Practice Group in Boston
Property Types
Office, Specialty, Multi-Family, Health Care
Markets
Boston, Providence
Bio
Michael Greeley is a Senior Managing Director of Newmark’s Medical-Academic Practice Group in Boston, overseeing capital markets for the team, which he joined in 2008. With a specialty in medical office building (MOB) investment sales, Greeley and his team, led by Rob Griffin, have been involved in the great majority of institutional healthcare trades in the Greater Boston market. Greeley is also a member of Newmark’s Healthcare Capital Markets Group, working alongside Jay Miele, Ben Appel and John Nero on medical office building sales across the US. The group’s 2021 activity includes several of the market’s most sought after institutional-quality medical office portfolios, totaling over 100 medical office buildings and multiple billions in total asset value.
Greeley has overseen dozens of landmark investment sales in the New England and East Coast markets, as well as hundreds of major leasing transactions with “meds & eds” clients. With a focus on submarkets surrounding hospitals, universities and medical-academic clusters, Mr. Greeley specializes in investment sales, institutional consulting, tenant and landlord advisory, and acquisition/disposition services.
Greeley and his team are extremely active on a national level in medical office building and healthcare real estate sales, with notable transactions that include the Boston Medical Center Portfolio ($180 million), Steward Health Care Portfolio ($100 million), 50 Staniford Street at MGH ($124 million), 109 Brookline Avenue ($270 million), 67 South Bedford at Lahey Clinic ($55 million), Harvard Vanguard-147 Milk Street ($48 million), Andover Medical Center ($55 million), Waldemere Medical Plaza ($47 million), Lifespan Ambulatory Care Center ($19 million) and Worcester BioTech Park at UMass ($40 million).
Greeley also oversees the firm’s Boston Private Capital Group, an investment sales unit focusing on middle market asset sales and operating within the Boston Capital Markets Group under the leadership of Rob Griffin.
Education
